4//SEC Filing
MacLean Michael F 4
Accession 0001599901-25-000161
CIK 0001599901other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:09 PM ET
Size
5.5 KB
Accession
0001599901-25-000161
Insider Transaction Report
Form 4
MacLean Michael F
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-08-06$42.73/sh−30,914$1,320,844→ 65,806 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on July 8, 2024.
- [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.15 to $43.92. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Avidity Biosciences, Inc.
CIK 0001599901
Entity typeother
Related Parties
1- filerCIK 0001383731
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:09 PM ET
- Size
- 5.5 KB